AI Assessment of Heterogeneous Histopathologic Brain Tumor Sub-regions: the RANO MICCAI BraTS-Path 2024 Challenge.

BACKGROUND: Automated classification of glioblastoma (IDH-wt, WHO CNS Gr.4) histopathologic sub-regions in whole slide images (WSI) is essential for quantitative tumor characterization, but faces substantial challenges from intra-tumoral heterogeneity and inter-observer annotation variability. The AI-RANO & RANO-Pathology working groups organized BraTS-Path 2024, representing the first international benchmarking environment and publicly available spatially annotated dataset, towards promoting the development and fair evaluation of Artificial Intelligence (AI) models to classify specific sub-regions: cellular tumor, pseudopalisading necrosis (PN), microvascular proliferation, geographic necrosis, infiltration into the cortex, and white matter penetration (WM). METHODS: Multi-institutional H&E-stained WSIs had reference standard samples generated by eight expert neuropathologists, following a rigorous peer review protocol, resulting in 309,118 data samples (training/validation/hold-out testing: 96,485/62,387/150,246). Quantitative performance evaluation of six AI approaches was conducted based on multiple metrics, including Accuracy and Matthew's correlation coefficient (MCC). A robust statistically-aware ranking strategy offered statistical significance of the final rankings. RESULTS: Top-performing approaches employed common strategies, including large pre-trained models, ensembling, and extensive data augmentation, reporting Accuracy=0.69 and MCC=0.58. Key challenges included severe class imbalance, hampering minority class performance, and inter-annotator variability, especially for ambiguous sub-regions such as PN or WM. CONCLUSIONS: BraTS-Path represents a valuable public resource for glioblastoma histopathologic sub-region assessment. Our findings indicate the specific task remaining an open research problem, highlighting the influence of rare sub-regions, the absence of a consistent "gold standard" annotation protocol, and the potential of foundation models to improve generalization, guiding future research toward developing more reliable AI tools for quantitative neuropathology.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2026-11-12
DOI
https://doi.org/10.1093/neuonc/noag283
Primary Topic
AI in cancer detection
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

AI Assessment of Heterogeneous Histopathologic Brain Tumor Sub-regions: the RANO MICCAI BraTS-Path 2024 Challenge.

Bjoern H. Menze, Susan Chang, Maria A. Gubbiotti, Shahriar Faghani et al.
PubMed
AI in cancer detection
article

AI Assessment of Heterogeneous Histopathologic Brain Tumor Sub-regions: the RANO MICCAI BraTS-Path 2024 Challenge.

Bjoern H. Menze, Susan Chang, Maria A. Gubbiotti, Shahriar Faghani, Bhakti Baheti, Sylwia Malec, Shubham Innani, Martin J. van den Bent, Matthew W. Pease, David Becerra, Marek Wodziński, Giselle Yvette Lopez, Dominic LaBella, Jason T. Huse, Mana Moassefi, Akis Linardos, Ujjwal Baid, Jeffrey J. Helgager, Lee Cooper, M. L. Miller, Benedikt Wiestler, Verena Chung, Alexandros Karargyris, Pallavi Tiwari, Spyridon Bakas, Siddhesh Pravin Thakur, MacLean P. Nasrallah, Patrick Y Wen, Valeria Barresi, Syed Rameem Zahra, Timothy Francis Cloughesy, Hasan Kassem, Sarthak Pati, Zhifan Jiang, Olivia K. Krebs, Marius George Linguraru, Jared T. Ahrendsen, Nelly Jazmín Sandino, Ankur Gupta, Ying Weng, Sanyukta Adap, Michael A. Vogelbaum, Jeff Rudie, Twinkle Dhingra, Raymond Huang, Rithik Kumar, Vansh Kakkar, Madhav Arora, Calixto-Hope G. Lucas, Maria Correia de Verdier, Alvaro A Sandino, William R Bell, Eduardo Romero, Henning Müller, Ke Chen, Carla Pitarch-Abaigar, Vinit, Juexin Zhang
article en

Abstract

BACKGROUND: Automated classification of glioblastoma (IDH-wt, WHO CNS Gr.4) histopathologic sub-regions in whole slide images (WSI) is essential for quantitative tumor characterization, but faces substantial challenges from intra-tumoral heterogeneity and inter-observer annotation variability. The AI-RANO & RANO-Pathology working groups organized BraTS-Path 2024, representing the first international benchmarking environment and publicly available spatially annotated dataset, towards promoting the development and fair evaluation of Artificial Intelligence (AI) models to classify specific sub-regions: cellular tumor, pseudopalisading necrosis (PN), microvascular proliferation, geographic necrosis, infiltration into the cortex, and white matter penetration (WM). METHODS: Multi-institutional H&E-stained WSIs had reference standard samples generated by eight expert neuropathologists, following a rigorous peer review protocol, resulting in 309,118 data samples (training/validation/hold-out testing: 96,485/62,387/150,246). Quantitative performance evaluation of six AI approaches was conducted based on multiple metrics, including Accuracy and Matthew's correlation coefficient (MCC). A robust statistically-aware ranking strategy offered statistical significance of the final rankings. RESULTS: Top-performing approaches employed common strategies, including large pre-trained models, ensembling, and extensive data augmentation, reporting Accuracy=0.69 and MCC=0.58. Key challenges included severe class imbalance, hampering minority class performance, and inter-annotator variability, especially for ambiguous sub-regions such as PN or WM. CONCLUSIONS: BraTS-Path represents a valuable public resource for glioblastoma histopathologic sub-region assessment. Our findings indicate the specific task remaining an open research problem, highlighting the influence of rare sub-regions, the absence of a consistent "gold standard" annotation protocol, and the potential of foundation models to improve generalization, guiding future research toward developing more reliable AI tools for quantitative neuropathology.

PubMed
Northwestern University (US), University of Geneva (CH), Uppsala University (SE), Brigham and Women's Hospital (US), Sher-e-Kashmir University of Agricultural Sciences and Technology of Kashmir (IN), Georgia Institute of Technology (US), Sage Bionetworks (US), Mayo Clinic (US), Children's National (US), The University of Texas MD Anderson Cancer Center (US), University of Wisconsin–Madison (US), University of Nottingham Ningbo China (CN), Harvard University (US), Johns Hopkins University (US), Emory University (US), University of California, Los Angeles (US), Duke University (US), HES-SO University of Applied Sciences and Arts Western Switzerland (CH), University of California, San Francisco (US), George Washington University (US), University of Zurich (CH), Columbia University Irving Medical Center (US), Johns Hopkins Medicine (US), Erasmus MC (NL), The Wallace H. Coulter Department of Biomedical Engineering (US), Moffitt Cancer Center (US), Netaji Subhas University of Technology (IN), Universidad Nacional de Colombia (CO), University of California San Diego (US), Dana-Farber Cancer Institute (US), Duke Medical Center (US), HES-SO Valais-Wallis (CH), Fondazione IRCCS Istituto Neurologico Carlo Besta (IT), Indiana University Indianapolis (US), Indiana University Melvin and Bren Simon Comprehensive Cancer Center (US), Indiana University School of Medicine (US), Sheikh Zayed Institute for Pediatric Surgical Innovation (US), Case Western Reserve University (US), Technical University of Munich (DE), AGH University of Krakow (PL), University of Pennsylvania (US)
Good health and well-being
AI in cancer detection
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon